CoChat

Geriatric Depression Treatment in Nonresponders to Selective Serotonin Reuptake Inhibitors

The DOI matches its Crossref record.

Abstract

BACKGROUND: Up to a third of elderly patients with major depressive disorder are treatment resistant, yet little objective evidence is available to guide the clinician in managing these patients. We report here our experience with elderly subjects with prospectively defined treatment-resistant depression in 2 separate research studies: one entailing an augmentation strategy, the other a change to venlafaxine extended release (XR). METHOD: Fifty-three elderly subjects with major depressive disorder according to DSM-IV criteria who failed treatment with paroxetine plus interpersonal psychotherapy received 1 to 3 trials of augmentation with bupropion sustained release, nortriptyline, or lithium. Successively fewer subjects entered each sequential trial of augmentation. Twelve subjects subsequently received venlafaxine XR monotherapy. Response to treatment was defined as a 17-item Hamilton Rating Scale for Depression score of < 10 for 3 weeks. RESULTS: Sixty percent of subjects (N = 32) responded to some form of augmentation, with 45% (24/53), 31% (5/16), and 43% (3/7) responding to the first, second, and third augmentation trials, respectively. The mean time to response after starting the first augmentation trial was 6.0 (SD = 5.8) weeks. Forty-two percent (N = 5) of the venlafaxine XR-treated subjects responded with the mean time to response of 6.4 (SE = 0.9) weeks. Adverse effects leading to treatment discontinuation and falls were more common in the augmentation subjects than in the venlafaxine XR subjects. CONCLUSION: We observed similar rates and speed of response with an augmentation strategy and a strategy of switching to venlafaxine XR in elderly subjects with prospectively defined treatment-resistant major depressive disorder. Venlafaxine XR was generally better tolerated than the augmentation strategies. Further investigation of venlafaxine XR as a preferred strategy for treatment-resistant geriatric depression is warranted.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v65n1208

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 86

Metadata

Authors
Whyte, E. M., Basinski, J., Farhi, P., Dew, M. A., Begley, A., Mulsant, B. H., & Reynolds, C. F.
Affiliations
University of Pittsburgh (US)
Venue
The Journal of Clinical Psychiatry
Published
2004-12-15
Volume
65
Issue
12
Pages
1634-1641
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2050851690
Cited by
86
References
0
Citations by year
2026: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 6 · 2012: 3
FWCI
4.35
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (MH-52247, P30MH052247, MH-37869, MH-069430, MH-43832, K23MH067710, K24MH069430, R01MH037869, MH067710, T32MH019986)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
geriatric depression, treatment-resistant depression, major depressive disorder, elderly patients, selective serotonin reuptake inhibitors, paroxetine, interpersonal psychotherapy, augmentation therapy, bupropion, nortriptyline, lithium, venlafaxine extended release, adverse effects, falls
MeSH terms
Venlafaxine Hydrochloride, Aged, Aged, 80 and over, Antidepressive Agents, Tricyclic, Combined Modality Therapy, Cyclohexanols, Delayed-Action Preparations, Major Depressive Disorder, Drug Therapy, Combination, Female, Humans, Lithium, Male, Nortriptyline, Psychiatric Status Rating Scales, Psychotherapy, Geriatric Assessment, Bupropion, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Paroxetine, Antidepressive Agents, Second-Generation, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Geriatric Depression Treatment in Nonresponders to Selective Serotonin Reuptake Inhibitors. https://app.cochat.ai/papers/10.4088/jcp.v65n1208
The paper
Whyte, E. M., Basinski, J., Farhi, P., Dew, M. A., Begley, A., Mulsant, B. H., & Reynolds, C. F. (2004). Geriatric Depression Treatment in Nonresponders to Selective Serotonin Reuptake Inhibitors. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v65n1208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.